Sapphiros
Boston
About Sapphiros
Sapphiros invests in growth-stage diagnostic companies, focusing on technologies that prioritize innovation and patient-centric approaches. The company possesses a portfolio of capabilities and technologies encompassing innovative sample collection, next-generation diagnostics, computational biology, and printed electronics. These elements contribute to the global accessibility of crucial diagnostic results for consumers.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 101 – 250
- Estimated revenue: $1K – $10K
- Total funding: $41.0M
- Funding stage: Early Stage Venture
- Last round: Series B (Jan 2024)
- Website: sapphiros.com
Industries & Categories
Business Development, Health Care, Health Diagnostics
Social Profiles
Canonical: https://fsome.com/organization/sapphiros-51320 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.